C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 453/02 (2006.01) A61K 31/435 (2006.01)
Patent
CA 2141806
2141806 9403451 PCTABS00030 Quinuclidine derivatives of formula (I), and their pharmaceutically acceptable salts, in which: R1 is hydrogen or hydroxy; R2 is hydrogen; or R1 and R2 are joined together so that CR1-CR2 is a double bond; X is selected from -CH2CH2-, -CH=CH-, -C=C-, -CH2O-, -OCH2-, -CH2NH-, -NHCH2-, -CH2CO-, -COCH2-, -CH2S(O)n- and -S(O)nCH2- wherein n is 0, 1 or 2; and Ar is phenyl which may be optionally unsubstituted or substituted by one or more substituents such as halogeno, hydroxy, amino, nitro, cyano, carboxy, carbamoyl, alkyl, alkenyl, alkynyl, alkoxy, alkylamino, dialkylamino, N-alkylcarbamoyl, N,N-di-alkylcarbamoyl, alkoxycarbonyl, alkylthio, alkylsulphinyl, alkylsulphonyl, halogeno alkyl, alkanoylamino, alkylenedioxy, alkanoyl and oxime derivatives thereof and O-alkyl ethers of said oximes; provided that when X is selected from -OCH2-, -NHCH2-, and -SCH2-, R1 is not hydroxy; inhibit squalene synthase and are useful in treating diseases or medical conditions in which inhibition of squalene synthase is desirable. The use of such heterocyclic derivatives in treating conditions such as hypercholesterolemia, and atherosclerosis is referred to as well as novel compounds, processes for their preparation and pharmaceutical compositions containing them.
Brown George R.
Mallion Keith B.
Whittamore Paul R. O.
Smart & Biggar
Zeneca Limited
LandOfFree
Quinuclidine derivatives as squalene synthase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinuclidine derivatives as squalene synthase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinuclidine derivatives as squalene synthase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1947110